PubMed Health⌕ Search

Biomedical subjects

Xiang-ru Li

Publications and source records attributed to Xiang-ru Li.

2 recordsLinked to original sources

[A novel spectral classifier based on coherence measure].

Classification and discovery of new types of celestial bodies from voluminous celestial spectra are two important issues in astronomy, and these two issues are treated separately in the literature to our knowledge. In the present paper, a novel coherence measure is introduced which can effectively measure the coherence of a new spectrum of unknown type with the training sampleslocated within its neighbourhood, then a novel classifier is designed based on this coherence measure. The proposed classifier is capable of carrying out spectral classification and knowledge discovery simultaneously. In particular, it can effectively deal with the situation where different types of training spectra exist within the neighbourhood of a new spectrum, and the traditional k-nearest neighbour method usually fails to reach a correct classification. The satisfactory performance for classification and knowledge discovery has been obtained by the proposed novel classifier over active galactic nucleus (AGNs) and active galaxies (AGs) data.

English Abstract↗

[Clinical observation on treatment of rheumatoid arthritis by combined therapy with methotrexate, sulfasalazine and Chinese herbal medicine].

OBJECTIVE: To observe the effect of Fengshi No. 1 (FS1) in treating patients with active stage of rheumatoid arthritis (RA). METHODS: Patients with RA were randomly divided into two groups, the 40 patients in the treated group were treated with combined therapy of methotrexate (MTX), sulfasalazine (SSZ) and FS1, and the 20 in the control groups were treated with MTX and SSZ alone. RESULTS: In the treated group, the total effective rate was 97.5%, the clinical controlled and markedly effective rate 95.0% and the occurrence rate of side-toxic reaction 10.0%, as compared with those in the control group, 60.0%, 20.0% and 45.0% respectively, the difference was significant (chi 2 = 11.91, 32.23 and 7.67 respectively, all P < 0.01). The effect in the treated group was superior to that in the control group in abating joint swelling and pain, improving function of joint, reducing immune indices and ameliorating iconographic features (P < 0.01 or P < 0.05). CONCLUSION: FS1 not only has the effects of anti-inflammation, analgesis, regulating immune reaction, but also could retard the occurring of bone destruction, reduce the toxic-side effects of MTX and SSZ.

Adult↗